Ophthalmology · Torrance, CA
NPI
1497943914
Since 2007
Specialty
Ophthalmology
Code 207W00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
20528 Hawthorne Blvd Ste 201
Torrance, CA, 90503
Phone (424) 247-9090
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.0M
37,472 services
Medicare patients, 2024
1,387
Average age 74
Drug cost, 2024
$173K
3,549 prescriptions
Company payments, 2025
$13K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mehran Taban was code J2777 (injection, faricimab-svoa, 0.1 mg), 6,900 times for 30 patients. In total Mehran Taban billed 37,472 services in 61 codes, and Medicare paid $3.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-01-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 6,900 | 30 | $27.70 | $191K |
| 92134 Computerized Ophthalmic Imaging | Office | 4,462 | 1,188 | $34.96 | $156K |
| 67028 Intravitreal Injection | Office | 3,975 | 503 | $102.98 | $409K |
| J7999 Compounded drug, not otherwise classified | Office | 3,544 | 486 | $73.50 | $260K |
| 67500 Eye | Office | 3,089 | 449 | $35.17 | $109K |
| 76512 Ultrasound - Nonspecific | Office | 2,210 | 885 | $41.77 | $92K |
| 92014 Ophthalmological E&M | Office | 1,996 | 1,095 | $106.36 | $212K |
| 92012 Ophthalmological E&M | Office | 1,652 | 561 | $79.67 | $132K |
| J3300 Injection, triamcinolone acetonide, preservative free, 1 mg | Office | 1,440 | 32 | $12.64 | $18K |
| 92235 Angiography | Office | 1,393 | 621 | $154.12 | $215K |
| 92250 Angiography | Office | 1,025 | 593 | $32.44 | $33K |
| 92201 Ophthalmological E&M | Office | 931 | 699 | $22.02 | $20K |
| J2781 Injection, pegcetacoplan, intravitreal, 1 mg | Office | 855 | 17 | $117.52 | $100K |
| 92242 Angiography | Office | 606 | 199 | $273.65 | $166K |
| 92287 Angiography | Office | 548 | 182 | $140.21 | $77K |
By year: 2022 $3.0M for 35,099 services; 2023 $3.3M for 42,107 services; 2024 $3.0M for 37,472 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mehran Taban prescribed most often to Medicare patients was Ciprofloxacin Hcl, with 1,413 prescriptions and refills. In total Mehran Taban wrote 3,549 Medicare prescriptions that cost $173K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ciprofloxacin Hcl Generic | 1,413 | 1,772 | 562 | $23K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 502 | 1,062 | 172 | $7,155 |
| Latanoprost Generic | 343 | 705 | 114 | $3,965 |
| Brimonidine Tartrate Generic | 290 | 635 | 107 | $11K |
| Timolol Maleate Generic | 253 | 630 | 93 | $2,843 |
| Prednisolone Acetate Generic | 186 | 371 | 101 | $9,371 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 99 | 132 | 68 | $6,358 |
| Lumigan Bimatoprost | 91 | 195 | 38 | $49K |
| Ofloxacin Generic | 48 | 66 | 33 | $617 |
| Simbrinza Brinzolamide/Brimonidine Tart | 46 | 72 | 13 | $8,936 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 36 | 66 | 13 | $5,967 |
| Dorzolamide Hcl Generic | 27 | 47 | 19 | $286 |
| Brinzolamide Generic | 18 | 36 | Under 11 | $2,943 |
| Moxifloxacin Moxifloxacin Hcl | 15 | 15 | Under 11 | $267 |
| Alphagan P Brimonidine Tartrate | 15 | 34 | Under 11 | $6,043 |
Brand drugs: 1,202 claims; generic drugs: 2,347 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mehran Taban $13K ($3,496 in general payments such as food, travel and fees and $9,904 for research) from 13 companies. The largest payer was Ocular Therapeutix, Inc. with $10K.
| Company | Payments | Amount |
|---|---|---|
| Ocular Therapeutix, Inc. OCUL | 6 | $10K |
| Genentech USA, Inc. ROG.SW | 2 | $2,403 |
| Alcon Vision LLC ALC | 2 | $171 |
| Astellas Pharma US Inc 4503.T | 5 | $112 |
| Abbvie Inc. ABBV | 3 | $71.26 |
| Harrow Eye, LLC | 2 | $55.12 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $39.38 |
| Apellis Pharmaceuticals, Inc. APLS | 1 | $31.67 |
| ANI Pharmaceuticals, Inc. ANIP | 1 | $29.63 |
| Amgen Inc. AMGN | 1 | $29.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.